维普中文期刊产品整合服务
20篇 您的检索式:作者名="PASELLO M"
    题名 作者 年代 出处 被引量
1High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro显示文摘de Mattei M Pellati A Pasello M 2002Osteoarthritis Cartilage2002,10,10:1
2Clinical im- pact of the methotrexate resistance - associated genes C - MYC and dihydrofolate reductase (DHFR) in high - grade osteosarcoma 显示文摘SCIONTI I MICHELACCI F PASELLO M 2008Ann Onco[2008,19,8:1
3High doses of glueosamine- HC1 have detrimental effects on bovine articular cartilage explants cultured in vitro 显示文摘Mattei M Pellati A Pasello M 2002Osteoarthritis Cartilage2002,10,10:1
4Effects of physical stimulation with electromagnetic field and insulin growth factor-Ⅰ treatment on proteoglycan synthesis of bovine articular cartilage显示文摘De Mattei M Pellati A Pasello M 2004Osteoarthritis Cartilage2004,12,10:1
5Clinical im- pact of the methotrexate resistance-associated genes C-MYC and dihydro folate reductase(DHFR) in high-grade osteosarcoma显示文摘Scionti F Michelacci M Pasello C M 2008Annals of Oncology2008,19,8:1
6Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteo- sarcoma显示文摘Scionti I Michelacci F Pasello M 2008Ann Oncol2008,19,8:1
7Clinicalimpact of the methotrexate resistance-associatedgenes C-MYC and dihydrofolate reductase (DHFR)in high-grade osteosarcoma显示文摘Scionti I Michelacci F Pasello M 2008Ann Oncol2008,19,8:1
8Emerging drugs for high- grade Osteosarcoma显示文摘Hattinger C Pasello M Ferrari S 2010Expert Opin Emerg Drugs2010,15,4:1
9Clinical impact of the methotrexatc resistance associated genes C-MYC and dihydrofolate reductase(DHFR) in high-grade osteosarcoma 显示文摘Scionti I Michelacci F Pasello M 2008Annals of Oncology2008,19,8:1
10High doses of glucosamine- HCl have detrimental effects on bovine articular cartilage explants cultured in vitro 显示文摘Mattei M Pellati A Pasello M 2002Osteoarthritis Cartilage2002,10,10:1
11Clinical impact of the methotrexate resistance associated genes C-MYC and dihydrofolate reductase(DHFR) in high-grade osteosarcoma显示文摘Scionti I Michelacci F Pasello M 2008Ann Oncol2008,19,:1
12Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants显示文摘De Mattei MM Pasello M Pellati A 2003Connect Tissue Res2003,44,34:1
13Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma 显示文摘Scionti I Michelaeci F Pasello M 2008Annals of Oncology2008,19,8:1
14Emerging drugs for high - grade osteosarcoma 显示文摘Hattinger CM Pasello M Ferrari M 2010Expert Opinion on Emer- ging Drugs2010,15,4:1
15Effects of elec- tromagnetic fields on proteoglycan metabolism of bovine ar- ticular cartilage explants显示文摘De Mattei M Pasello M Pellati A 2003Connect Tissue Res2003,44,34:1
16Effects of physi- cal stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bo- vine articular cartilage显示文摘De Mattei M Pellati A Pasello M 2004Osteoarthritis Cartilage2004,12,10:1
17May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol显示文摘Serra M Pasello M Manara MC 2006Int J Oncol2006,29,6:1
18Clincal impact of the methotrexate resistance-associated genes CMYC and dihydrofolate reductase(DHFR)in highgrade osteosarcoma显示文摘Scionti I Michelacci F Pasello M 2008Annals of Oncology2008,19,:1
194-Demethoxy-3'- deamino-3 '-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU- 159548 ) : a promis- ing new candidate for chemotherapeutic treatment of osteosarcoma patients 显示文摘Pasello M Hattinger CM Stoieo G 2005Eur J Cancer2005,41,14:1
20Can P-glycoprotein status be used to stratify highgrade osteosarcoma patients? Results from the Italian/ Scandinavian Sarcoma Group 1 treatment protocol显示文摘Serra M Pasello M Manara MC 2006Int J Oncol2006,29,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费